$AEGLEA BIOTHERAPEUTICS INC CVR(AGLE.CVR.US)$$Aeglea BioTherapeutics(AGLE.US)$ In connection with the transactions, a non-transferrable contingent value right (a "CVR") will be distributed to Aeglea stockholders of record as of the close of business on July 3, 2023, but will not be distributed to holders of shares of common stock or preferred stock issued to Spyre or the PIPE investors in the transaction. Holders of the CVR will be entitled to receive certain stock and/or cash...
agreeable Hound_0795 : 我也收到了但自動扣除稅
Stockmarker樓主 agreeable Hound_0795: 同樣,他們扣除了相當多
agreeable Hound_0795 : 你至少給你 15 美元?
Stockmarker樓主 agreeable Hound_0795: 對我來說 $19 扣除虛弱
agreeable Hound_0795 Stockmarker樓主: 好吧,至少有剩餘的
查看更多評論...